Yahoo Web Search

Sign In

Search results

  1. www.sanofiflu.comSanofi flu - Trivalent Influenza Vaccines for Influenza Type A...

    Sanofi offers a range of trivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B virus. Please see Important Safety Information or Prescribing Information.

  2. www.sanofiflu.com › Sanofi Flu Vaccine Portfolio GuideQuadrivalent Influenza Vaccines for Influenza Type A and B -...

    INDICATIONS. Fluzone, Flublok, and Fluzone High-Dose are vaccines indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. Fluzone is approved for use in persons 6 months of age and older.

  3. www.sanofi.com › en › your-healthInfluenza - Sanofi

    Learn about Sanofi's dedication to flu prevention using cutting-edge vaccines designed to protect from severe complications and enhance public health. Find out more about Influenza and Sanofi's contribution to research and vaccines.

  4. www.sanofiflu.com › fluzone-high-dose-influenza-vaccineFluzone High-Dose (Influenza Vaccine ) for 65+ | Sanofiflu.com

    Fluzone High-Dose is the first and only influenza vaccine proven superior to a standard-dose flu vaccine in adults aged 65+ and has more than 12 years of real-world evidence (2009-2010 to 2019-2020, and 2021-2022) in the prevention of influenza outcomes including influenza hospitalization.

  5. www.news.sanofi.us › 2022/07/01-Sanofi-flu-vaccines-licensedSanofi flu vaccines licensed and approved for 2022-2023 influenza...

    Jul 1, 2022 · With protection against four flu strains, Fluzone High-Dose is the only influenza vaccine licensed for use in adults 65 years of age and older to have demonstrated superior efficacy in a randomized controlled trial versus a standard dose influenza vaccine for the prevention of laboratory-confirmed influenza illness and the only ...

  6. www.sanofi.com › assets › dotcomMedia Update - Sanofi

    Oct 7, 2021 · 7 October 2021. Interim results from the first co-administration descriptive study of Sanofi’s Fluzone® High-Dose Quadrivalent vaccine with Moderna’s COVID-19 mRNA investigational booster dose show that the administration of the vaccines at the same visit had similar immunogenicity responses and a similar safety and tolerability ...

  7. www.sanofi.us › en › your-healthFlu Awareness: Understanding Influenza| Sanofi USA

    Oct 1, 2023 · The best way to help protect from the virus is an annual flu vaccination. 1 It has been shown to help lower the risk of catching the flu as well as help reduce the severity of illness for those who still experience symptoms of the flu. 1